Literature DB >> 946507

Prevention of venous thrombosis with small, subcutaneous doses of heparin.

A S Gallus, J Hirsh, S E O'Brien, J A McBride, R J Tuttle, M Gent.   

Abstract

The effect of low-dose heparin prophylaxis on venous thrombosis and bleeding after major elective surgery was studied in a prospective controlled study of 820 patients. The total incidence of venous thrombosis detected with leg-scanning using fibrinogen labeled with radioactive iodine (125I) was reduced from 16.0% in the control group to 4.2% in treated patients. More important, the incidence of popliteal or femoral vein thrombosis was reduced from 2.9% to 1.0%. Prophylaxis resulted in a slight increase in bleeding-minor wound hematoma, mean volume of blood transfused, and a post-operative hematocrit fall in treated patients. However, increased bleeding was clinically minor, and prophylaxis was well tolerated.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 946507

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  15 in total

1.  Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial.

Authors:  R S McLeod; W H Geerts; K W Sniderman; C Greenwood; R C Gregoire; B M Taylor; R E Silverman; K G Atkinson; M Burnstein; J C Marshall; C J Burul; D R Anderson; T Ross; S R Wilson; P Barton
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

2.  Surgical debate. We still have insufficient evidence to support perioperative heparin prophylaxis against venous thromboembolism.

Authors:  G Sutton; S Hosking; C D Johnson
Journal:  Ann R Coll Surg Engl       Date:  1991-03       Impact factor: 1.891

Review 3.  The risk of thromboembolism in patients undergoing colorectal surgery.

Authors:  R S McLeod
Journal:  Drugs       Date:  1996       Impact factor: 9.546

4.  Prevention of pulmonary emboli in hospitalized patients.

Authors:  J C Hubbard
Journal:  Can Fam Physician       Date:  1983-02       Impact factor: 3.275

5.  The current status of low-dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism.

Authors:  V V Kakkar
Journal:  World J Surg       Date:  1978-01       Impact factor: 3.352

6.  Can we really prevent postoperative pulmonary emboli?

Authors:  J R Mitchell
Journal:  Br Med J       Date:  1979-06-09

7.  Venous thromboembolism in urologic surgery: prophylaxis, diagnosis, and treatment.

Authors:  Kevin R Rice; Stephen A Brassell; David G McLeod
Journal:  Rev Urol       Date:  2010

8.  Heparan sulfate/heparin glycosaminoglycan binding alters inhibitory profile and enhances anticoagulant function of conserved Amblyomma americanum tick saliva serpin 19.

Authors:  Željko M Radulović; Albert Mulenga
Journal:  Insect Biochem Mol Biol       Date:  2016-11-12       Impact factor: 4.714

9.  Cost-effectiveness of primary and secondary prevention of fatal pulmonary embolism in high-risk surgical patients.

Authors:  R D Hull; J Hirsh; D L Sackett; G L Stoddart
Journal:  Can Med Assoc J       Date:  1982-11-15       Impact factor: 8.262

Review 10.  Antithrombotic drugs: part I.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.